AI/ML Innovations Inc. Key Updates to Upcoming Annual and Special Meeting
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has announced key updates to its upcoming annual general and special meeting scheduled for February 21, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has announced key updates to its upcoming annual general and special meeting scheduled for February 21, 2025. The company plans to increase its board seats from three to four and has nominated Dr. Drew Dundas to fill the additional position.
Dr. Dundas brings over 20 years of technology and research leadership experience, currently serving as Chief Technology Officer at Earlens His extensive background includes roles as President and CTO of Soundhawk , Director of Audiology at UCSF Medical Center, and research contributions at Starkey Hearing Technologies. He holds a PhD in Audiology & Biomedical Engineering from Vanderbilt University.
AIML focuses on artificial intelligence and machine learning in digital health through various subsidiaries and partnerships, including Quantum Sciences, NeuralCloud Solutions, Health Gauge (95.2% owned), Tech2Heal (11.11% owned), and AI Rx (70% owned).
Positive
- Addition of independent director with specialized technology expertise
- Strategic expansion of board oversight capacity
- Diverse portfolio of AI-driven healthcare solutions through multiple subsidiaries
Negative
- None.
Details
News Market Reaction – AIMLF
The recorded move for AIMLF in the trading session of this news was -3.28%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The number of board seats to be set at four, making room for an additional independent director
Drew Dundas nominated to AI/ML Innovations Board of Directors
VANCOUVER, BC / ACCESS Newswire / February 20, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to provide important updates regarding its upcoming annual general and special meeting scheduled for February 21, 2025 ("AGM"). Further to the management information circular dated January 9, 2025 ("Circular") AIML intends to increase the number of board seats from three (3) to four (4). Further the Company is excited to announce the nomination of Dr. Drew Dundas to fill the additional board position, enhancing the Company's governance with independent oversight and specialized expertise in technology.
Dr. Dundas brings over two decades of leadership in technology and research, currently serving as Chief Technology Officer at Earlens Corporation, where he leads research and development efforts across various teams, including research, audiology, marketing, and clinical. Prior to Earlens, Dr. Dundas served as President and CTO of Soundhawk Corporation and Director of Audiology at UCSF Medical Center. His background also includes research at Starkey Hearing Technologies, where he contributed to the development of groundbreaking audiological technologies. Dr. Dundas holds a PhD in Audiology & Biomedical Engineering from Vanderbilt University, a Master of Arts from The University of Akron in Audiology, and a BSc from McMaster University. In addition, Dr. Dundas is a fellow of the American Academy of Audiology.
Mark Orsmond, Executive Chairman of AIML, shared his enthusiasm: "We are thrilled to welcome Drew to our Board. His wealth of expertise in both the business and healthtech realms will be instrumental as AIML accelerates its portfolio of AI-driven healthcare solutions and moves toward the next stage of growth."
For more information about the AGM, including voting and access details, please refer to the Company's Circular.
For more information about AIML:
For detailed information please see AIML's website or the Company's filed documents at www.sedarplus.ca.
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.
About AI/ML Innovations Inc. https://aiml-innovations.com/
AIML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence: (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through its acquisition of Quantum Sciences Ltd. (
On behalf of the Board of Directors:
Mark Orsmond, Executive Chairman
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: AI/ML Innovations, Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.